Published: 19 December 2020
Author(s): Richard Conway, Declan Byrne, Seán Cournane, Deirdre O'Riordan, Seamus Coveney, Bernard Silke
Issue: May 2021
Section: Original article

Troponin assays are a relatively common laboratory diagnostic request in emergency medical admissions. Following cardiac injury these macromolecules diffuse into the cardiac interstitium with subsequent detection in the peripheral circulation. We have previously shown that a clinical decision to request high-sensitivity cardiac troponin T (hscTnT) was a prognostic marker and semi-quantitative mortality predictor in unselected emergency medical admissions [1]. Cardiac-specific troponins are useful because they convey prognostic information that can influence therapeutic decisions, [2] not alone for the diagnosis of acute coronary syndromes [3], but also in non-cardiac presentations [4-17].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.